FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Hybrid Pharma | 26436-5618 | 26436-5618-3 | Estriol 1mg/gm | Estriol 1mg/gm | 1 mg/1 g | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5604 | 26436-5604-2 | Ethanol | Ethanol | 95 mL/100 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5101 | 26436-5101-3 | Glutamine 25mg/mL | Glutamine 25mg/mL | 25 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5593 | 26436-5593-3 | Glutamine Arginine HCl Carnitine 25/100/100mg/mL | Glutamine (L), Arginine HCl, Carnitine (L) | 100 mg/1 mL; 100 mg/1 mL; 25 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5028 | 26436-5028-3 | Glutathione | Glutathione | 100 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5227 | 26436-5227-3 | Glycine 100mg/mL | Glycine 100mg/mL | 100 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5169 | 26436-5169-3 | Isoleucine/Leucine/Valine (BCAA) 15/10/40mg/mL | Isoleucine/Leucine/Valine | 15 mg/1 mL; 40 mg/1 mL; 10 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5311 | 26436-5311-1 | LET Topical Gel | LET Topical Gel | .5 mg/1 mL; 5 mg/1 mL; 40 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5480 | 26436-5480-1 | Lidocaine 1% PF | Lidocaine 1% PF | 10 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5324 | 26436-5324-1 | LIDOCAINE/TETRACAINE 23%/7% | LIDOCAINE TETRACAINE 23%/7% | 70 mg/1 g; 230 mg/1 g | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5620 | 26436-5620-1 | LIDOCAINE/TETRACAINE 23%/7% | LIDOCAINE TETRACAINE 23%/7% | 70 mg/1 g; 230 mg/1 g | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5625 | 26436-5625-1 | LIDOCAINE/TETRACAINE/ BUPIVACAINE HCL 20%/7%/3% | LIDOCAINE/TETRACAINE/ BUPIVACAINE HCL 20/7/3 | 70 mg/1 g; 200 mg/1 g; 30 mg/1 g | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5624 | 26436-5624-1 | LIDOCAINE/TETRACAINE/ PHENYLEPHRINE HCL 20%/7%/0.5% | LIDOCAINE/TETRACAINE/ PHENYLEPHRINE HCL 20/7/0.5 | 70 mg/1 g; 200 mg/1 g; 5 mg/1 g | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5080 | 26436-5080-3 | Lysine 100mg/mL | Lysine Hydrochloride 100mg/mL | 100 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5596 | 26436-5596-3 | m-B12 MIC | Methylcobalamin Methionine Inositol Choline Chloride | 25 mg/1 mL; 50 mg/1 mL; 50 mg/1 mL; 1 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5105 | 26436-5105-5 | Magnesium Chloride | Magnesium Chloride | 200 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5015 | 26436-5015-3 | Methylcobalamin | Methylcobalamin | 1 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5354 | 26436-5354-1 | Methylene Blue 5mg/mL | Methylene Blue 5mg/mL | 5 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5595 | 26436-5595-3 | MIC | Methionine Inositol Choline chloride | 25 mg/1 mL; 50 mg/1 mL; 50 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-2632 | 26436-2632-3 | MIC | Methionine Inositol Choline | 25 mg/1 mL; 50 mg/1 mL; 50 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5558 | 26436-5558-5 | NAD | NICOTINAMIDE ADENINE DINUCLEOTIDE 50mg | 50 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5558 | 26436-5558-0 | NAD | NICOTINAMIDE ADENINE DINUCLEOTIDE 50mg | 50 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-0724 | 26436-0724-9 | Naltrexone 2 | Naltrexone 2mg | 2 mg | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5614 | 26436-5614-1 | Naltrexone HCl | Naltrexone HCl | 2.5 mg | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5629 | 26436-5629-1 | Naltrexone HCL 2mg | Naltrexone HCL 2mg | 2 mg | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5633 | 26436-5633-1 | Naltrexone HCL 6mg | Naltrexone HCL 6mg | 6 mg | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5066 | 26436-5066-3 | Niacinamide 100mg/mL | Niacinamide 100mg/mL | 100 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5007 | 26436-5007-3 | Panthenol 250mg/mL | Panthenol 250mg/mL | 250 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5580 | 26436-5580-1 | Phenol | Phenol | 50 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5130 | 26436-5130-1 | Phenylephrine 1mg/ml | Phenylephrine 1mg/mL | 1 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-6001 | 26436-6001-1 | POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | .2 meq/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-6028 | 26436-6028-3 | Procaine Hydrochloride | Procaine Hydrochloride | 20 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5248 | 26436-5248-1 | Progesterone 125mg | Progesterone 125mg | 125 mg | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5152 | 26436-5152-1 | Progesterone 150mg | Progesterone 150mg | 150 mg | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5617 | 26436-5617-1 | Progesterone 25mg | Progesterone | 25 mg | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5380 | 26436-5380-1 | Progesterone 65mg | Progesterone 65mg | 60 mg | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5183 | 26436-5183-5 | Quadmix 60/30/3/0.03 | Quadmix 60/30/3/0.03 | 30 mg/1 mL; 60 ug/1 mL; 3 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5608 | 26436-5608-3 | SEMAGLUTIDE | SEMAGLUTIDE | 2.5 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5608 | 26436-5608-2 | SEMAGLUTIDE | SEMAGLUTIDE | 2.5 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5608 | 26436-5608-1 | SEMAGLUTIDE | SEMAGLUTIDE | 2.5 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5608 | 26436-5608-4 | SEMAGLUTIDE | SEMAGLUTIDE | 2.5 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5607 | 26436-5607-9 | Sermorelin Acetate | Sermorelin Acetate 1mg/mL | 1 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5424 | 26436-5424-1 | Sermorelin acetate 300mcg | Sermorelin acetate 300 mcg | 300 ug | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5591 | 26436-5591-1 | Sildenafil | Sildenafil | 110 mg | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-0059 | 26436-0059-2 | Tadalafil | Tadalafil | 20 mg | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5613 | 26436-5613-1 | TADALAFIL | TADALAFIL | 12 mg | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5024 | 26436-5024-3 | Taurine 50mg/mL | Taurine 50mg/mL | 50 mg/1 mL | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5616 | 26436-5616-3 | TESTOSTERONE | TESTOSTERONE | 1 mg/1 g | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-0163 | 26436-0163-3 | TESTOSTERONE 10% | TESTOSTERONE 10 | 100 mg/1 g | 2024-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5280 | 26436-5280-1 | TESTOSTERONE 2.5% | TESTOSTERONE 2.5% | 25 mg/1 g | 2024-2 | valid | 2026-09-18 |